Charles Schwab’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.4M | Buy |
2,350,405
+345,466
| +17% | +$2.68M | ﹤0.01% | 1682 |
|
|
2025
Q4 | $15.6M | Buy |
2,004,939
+10,535
| +0.5% | +$76.2K | ﹤0.01% | 1902 |
|
|
2025
Q3 | $15.1M | Buy |
1,994,404
+24,529
| +1% | +$204K | ﹤0.01% | 1898 |
|
|
2025
Q2 | $17.7M | Buy |
1,969,875
+47,837
| +2% | +$445K | ﹤0.01% | 1740 |
|
|
2025
Q1 | $14.4M | Sell |
1,922,038
-57,954
| -3% | -$467K | ﹤0.01% | 1789 |
|
|
2024
Q4 | $14.9M | Buy |
1,979,992
+91,998
| +5% | +$698K | ﹤0.01% | 1840 |
|
|
2024
Q3 | $14.3M | Buy |
1,887,994
+102,860
| +6% | +$782K | ﹤0.01% | 1865 |
|
|
2024
Q2 | $11M | Buy |
1,785,134
+53,331
| +3% | +$294K | ﹤0.01% | 1998 |
|
|
2024
Q1 | $8.8M | Buy |
1,731,803
+137,367
| +9% | +$773K | ﹤0.01% | 2049 |
|
|
2023
Q4 | $9.55M | Buy |
1,594,436
+133,629
| +9% | +$774K | ﹤0.01% | 2008 |
|
|
2023
Q3 | $10.3M | Buy |
1,460,807
+19,402
| +1% | +$139K | ﹤0.01% | 1891 |
|
|
2023
Q2 | $10.1M | Buy |
1,441,405
+18,285
| +1% | +$147K | ﹤0.01% | 1904 |
|
|
2023
Q1 | $11.9M | Buy |
1,423,120
+2,733
| +0.2% | +$26.3K | ﹤0.01% | 1790 |
|
|
2022
Q4 | $16.3M | Buy |
1,420,387
+34,239
| +2% | +$427K | 0.01% | 1577 |
|
|
2022
Q3 | $17.5M | Buy |
1,386,148
+29,145
| +2% | +$375K | 0.01% | 1471 |
|
|
2022
Q2 | $14.4M | Buy |
1,357,003
+10,162
| +0.8% | +$105K | 0.01% | 1625 |
|
|
2022
Q1 | $21.9M | Buy |
1,346,841
+72,026
| +6% | +$1.16M | 0.01% | 1475 |
|
|
2021
Q4 | $17.7M | Buy |
1,274,815
+30,649
| +2% | +$406K | 0.01% | 1680 |
|
|
2021
Q3 | $17.9M | Buy |
1,244,166
+17,055
| +1% | +$269K | 0.01% | 1671 |
|
|
2021
Q2 | $19.4M | Buy |
1,227,111
+20,145
| +2% | +$274K | 0.01% | 1611 |
|
|
2021
Q1 | $12.3M | Buy |
1,206,966
+38,275
| +3% | +$395K | ﹤0.01% | 1838 |
|
|
2020
Q4 | $8.71M | Sell |
1,168,691
-1,355
| -0.1% | -$6.99K | ﹤0.01% | 1942 |
|
|
2020
Q3 | $4.02M | Buy |
1,170,046
+242,102
| +26% | +$1.04M | ﹤0.01% | 2181 |
|
|
2020
Q2 | $4.42M | Buy |
927,944
+68,937
| +8% | +$275K | ﹤0.01% | 2084 |
|
|
2020
Q1 | $1.72M | Buy |
859,007
+23,758
| +3% | +$65.4K | ﹤0.01% | 2325 |
|
|
2019
Q4 | $2.88M | Buy |
835,249
+259,443
| +45% | +$653K | ﹤0.01% | 2298 |
|
|
2019
Q3 | $1.65M | Sell |
575,806
-76,927
| -12% | -$239K | ﹤0.01% | 2447 |
|
|
2019
Q2 | $2.47M | Sell |
652,733
-126,632
| -16% | -$762K | ﹤0.01% | 2300 |
|
|
2019
Q1 | $6.34M | Buy |
779,365
+181,543
| +30% | +$1.55M | ﹤0.01% | 1861 |
|
|
2018
Q4 | $4.83M | Sell |
597,822
-18,081
| -3% | -$141K | ﹤0.01% | 1921 |
|
|
2018
Q3 | $4.7M | Buy |
615,903
+96,843
| +19% | +$650K | ﹤0.01% | 2076 |
|
|
2018
Q2 | $2.98M | Buy |
519,060
+28,084
| +6% | +$155K | ﹤0.01% | 2248 |
|
|
2018
Q1 | $2.34M | Sell |
490,976
-5,816
| -1% | -$29.9K | ﹤0.01% | 2270 |
|
|
2017
Q4 | $2.44M | Buy |
496,792
+176,714
| +55% | +$856K | ﹤0.01% | 2236 |
|
|
2017
Q3 | $1.68M | Buy |
320,078
+12,267
| +4% | +$62.8K | ﹤0.01% | 2348 |
|
|
2017
Q2 | $1.71M | Sell |
307,811
-25,562
| -8% | -$156K | ﹤0.01% | 2271 |
|
|
2017
Q1 | $2.8M | Buy |
333,373
+62,792
| +23% | +$437K | ﹤0.01% | 2059 |
|
|
2016
Q4 | $1.71M | Buy |
270,581
+13,398
| +5% | +$69.7K | ﹤0.01% | 2239 |
|
|
2016
Q3 | $1.14M | Buy |
257,183
+11,454
| +5% | +$45.8K | ﹤0.01% | 2375 |
|
|
2016
Q2 | $698K | Buy |
245,729
+3,528
| +1% | +$11K | ﹤0.01% | 2467 |
|
|
2016
Q1 | $686K | Sell |
242,201
-23,769
| -9% | -$105K | ﹤0.01% | 2464 |
|
|
2015
Q4 | $2.75M | Buy |
265,970
+20,210
| +8% | +$201K | ﹤0.01% | 1905 |
|
|
2015
Q3 | $2.8M | Buy |
245,760
+35,885
| +17% | +$479K | ﹤0.01% | 1857 |
|
|
2015
Q2 | $3.13M | Buy |
209,875
+5,769
| +3% | +$65.6K | ﹤0.01% | 1848 |
|
|
2015
Q1 | $1.84M | Sell |
204,106
-274,277
| -57% | -$2.84M | ﹤0.01% | 2095 |
|
|
2014
Q4 | $5.82M | Buy |
478,383
+28,362
| +6% | +$313K | 0.01% | 1333 |
|
|
2014
Q3 | $4.4M | Buy |
450,021
+200,061
| +80% | +$2.45M | 0.01% | 1473 |
|
|
2014
Q2 | $3.19M | Buy |
249,960
+226,060
| +946% | +$2.2M | 0.01% | 1708 |
|
|
2014
Q1 | $253K | Hold |
23,900
| – | – | ﹤0.01% | 2872 |
|
|
2013
Q4 | $182K | Hold |
23,900
| – | – | ﹤0.01% | 2973 |
|
|
2013
Q3 | $182K | Hold |
23,900
| – | – | ﹤0.01% | 2949 |
|
|
2013
Q2 | $39K | Buy |
+23,900
| New | +$41.2K | ﹤0.01% | 3038 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC